Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

ABSTRACT The median frequency of convulsive seizures per month decreased from 12.4 to 5.9 with cannabidiol, as compared with a decrease from 14.9 to 14.1 with placebo (adjusted median difference between the cannabidiol group and the placebo group in change in seizure frequency, −22.8 percentage points; 95% confidence interval [CI], −41.1 to −5.4; P=0.01). The …

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome Read More »